Central Volume Target Overlap and Esophageal Dose Predict for Toxicity in a Prospective Study of Reirradiation for Non-Small Cell Lung Carcinoma Using Proton Therapy

International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2016.06.433
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Prospective Study of Proton-Beam Radiation Therapy for Limited-Stage Small Cell Lung Cancer

Cancer
Cancer ResearchOncology
2017English

Toxicity and Efficacy of Thoracic Reirradiation With Split-Course Chemoradiation Therapy for the Curative Treatment of Recurrent Non-Small Cell Lung Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Reirradiation Utilizing Proton Radiation Therapy May Improve Toxicity Free Survival in Patients With Small-Volume, Recurrent Head and Neck Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Prospective Study of Patient-Reported Symptom Burden in Patients With Non–Small-Cell Lung Cancer Undergoing Proton or Photon Chemoradiation Therapy

Journal of Pain and Symptom Management
NeurologyAnesthesiologyPain MedicineNursing
2016English

Combination Therapy of Large Dose of Carboquone and Radiation for Small Cell Carcinoma of the Lung.

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
1985English

SLC39A6: A Potential Target for Diagnosis and Therapy of Esophageal Carcinoma

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2015English

Planning Target Volume and FDG-PET Maximum Standardized Uptake Value, but Not Dosimetric Parameters of Target Coverage, Predict for Local Recurrence After Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Hmgb1: A Potential Therapeutic Target for Non-Small Cell Lung Cancer

Lettters in Health & Biological Sciences
2016English

Concurrent Genetic Alterations Predict the Progression to Target Therapy in EGFR-mutated Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy